Clinical Trial Update: Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) [Phase 2]

View source ↗

Summary

Phase 2 CURB-2 trial evaluating extended-release naltrexone and monthly extended-release buprenorphine for Cocaine Use Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)
• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cocaine Use Disorder | Phase 2 | Status: COMPLETED